These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 29337987)
21. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Kohler EM; Chandra SH; Behrens J; Schneikert J Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359 [TBL] [Abstract][Full Text] [Related]
22. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma]. Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080 [TBL] [Abstract][Full Text] [Related]
23. Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma. Zhang F; Yang Q; Meng F; Shi H; Li H; Liang Y; Han A Mol Carcinog; 2013 Aug; 52(8):603-10. PubMed ID: 22431469 [TBL] [Abstract][Full Text] [Related]
24. Confirmation of a Rare Genetic Leukoencephalopathy due to a Novel Bi-allelic Variant in RPIA. Kaur P; Wamelink MMC; van der Knaap MS; Girisha KM; Shukla A Eur J Med Genet; 2019 Aug; 62(8):103708. PubMed ID: 31247379 [TBL] [Abstract][Full Text] [Related]
25. The immune response to RNA suppresses nucleic acid synthesis by limiting ribose 5-phosphate. Bhattacharjee P; Wang D; Anderson D; Buckler JN; de Geus E; Yan F; Polekhina G; Schittenhelm R; Creek DJ; Harris LD; Sadler AJ EMBO J; 2024 Jul; 43(13):2636-2660. PubMed ID: 38778156 [TBL] [Abstract][Full Text] [Related]
26. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer. Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543 [TBL] [Abstract][Full Text] [Related]
27. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis. Breuhahn K; Singh S; Schirmacher P; Bläker H J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352 [TBL] [Abstract][Full Text] [Related]
28. Origin of Somatic Mutations in β-Catenin versus Adenomatous Polyposis Coli in Colon Cancer: Random Mutagenesis in Animal Models versus Nonrandom Mutagenesis in Humans. Yang D; Zhang M; Gold B Chem Res Toxicol; 2017 Jul; 30(7):1369-1375. PubMed ID: 28578586 [TBL] [Abstract][Full Text] [Related]
29. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904 [TBL] [Abstract][Full Text] [Related]
30. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930 [TBL] [Abstract][Full Text] [Related]
31. Expression and mutation pattern of β-catenin and adenomatous polyposis coli in colorectal cancer patients. Abdelmaksoud-Damak R; Miladi-Abdennadher I; Triki M; Khabir A; Charfi S; Ayadi L; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R Arch Med Res; 2015 Jan; 46(1):54-62. PubMed ID: 25660336 [TBL] [Abstract][Full Text] [Related]
32. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383 [TBL] [Abstract][Full Text] [Related]
33. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953 [TBL] [Abstract][Full Text] [Related]
34. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling. Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922 [TBL] [Abstract][Full Text] [Related]
35. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation. Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699 [TBL] [Abstract][Full Text] [Related]
36. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. Cong F; Zhang J; Pao W; Zhou P; Varmus H BMC Mol Biol; 2003 Sep; 4():10. PubMed ID: 14516475 [TBL] [Abstract][Full Text] [Related]
37. Frequent activation of the β-catenin gene in sporadic colorectal carcinomas: A mutational & expression analysis. Anwar M; Kochhar R; Singh R; Bhatia A; Vaiphei K; Mahmood A; Mahmood S Mol Carcinog; 2016 Nov; 55(11):1627-1638. PubMed ID: 26373808 [TBL] [Abstract][Full Text] [Related]
38. Signal transduction cross-talk during colorectal tumorigenesis. Liu X; Lazenby AJ; Siegal GP Adv Anat Pathol; 2006 Sep; 13(5):270-4. PubMed ID: 16998321 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis. Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021 [TBL] [Abstract][Full Text] [Related]
40. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44. Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]